Hi-Tech CEO Wheat Arrested In FDA Investigation Of Steroid-Spiked Supplements
This article was originally published in The Rose Sheet
Hi-Tech Pharmaceuticals CEO Jared Wheat and an associate face 18 criminal charges in federal court alleging they falsified FDA documents and distributed as supplements products containing steroid ingredient. Wheat is appealing the indictment to federal circuit court.
You may also be interested in...
As Hi-Tech Argues For DMHA Use, DMAA Seizure Falls In FDA's Criminal Case, Contempt Stands In FTC Complaint
Hi-Tech Pharmaceuticals granted motion in federal court to have $19m in seized DMAA products returned, though the order noted sales of the products are prohibited. As Hi-Tech seeks court order that FDA is wrong about DMAA, an appellate court upholds $40m contempt fine against firm in FTC complaint.
GNC online sourcing deal; Gaspari CEO has full control of brand; medical cannabis research partnership in Canada; Momentous occasion of plant protein launch; Innotech Nutrition in US with Colflex preventative spray; AMP Energy wants entrepreneurs; and Nutrition 21's Nitrosigine in C4 Ultimate Shred.
One of the undeclared stimulant ingredients, 2-amino-6-methylheptane, or DMHA, is new on FDA's radar for violative ingredients used in products marketed as dietary supplements, while the other, 1,3-dimethylamylamine, DMAA, has long been a target of agency enforcement in the supplement sector.